DE602006018038D1 - Molekulares verfahren zur diagnose von prostatakrebs - Google Patents
Molekulares verfahren zur diagnose von prostatakrebsInfo
- Publication number
- DE602006018038D1 DE602006018038D1 DE602006018038T DE602006018038T DE602006018038D1 DE 602006018038 D1 DE602006018038 D1 DE 602006018038D1 DE 602006018038 T DE602006018038 T DE 602006018038T DE 602006018038 T DE602006018038 T DE 602006018038T DE 602006018038 D1 DE602006018038 D1 DE 602006018038D1
- Authority
- DE
- Germany
- Prior art keywords
- marker genes
- diagnosis
- prostate cancer
- prostate tissue
- molecular method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title abstract 2
- 206010060862 Prostate cancer Diseases 0.000 title 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 239000003550 marker Substances 0.000 abstract 4
- 108090000623 proteins and genes Proteins 0.000 abstract 4
- 210000002307 prostate Anatomy 0.000 abstract 3
- 230000014509 gene expression Effects 0.000 abstract 1
- 238000013188 needle biopsy Methods 0.000 abstract 1
- 230000002018 overexpression Effects 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
- 230000009452 underexpressoin Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57434—Specifically defined cancers of prostate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71650705P | 2005-09-14 | 2005-09-14 | |
| PCT/CA2006/001477 WO2007030919A1 (en) | 2005-09-14 | 2006-09-08 | Molecular method for diagnosis of prostate cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602006018038D1 true DE602006018038D1 (de) | 2010-12-16 |
Family
ID=37864588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602006018038T Active DE602006018038D1 (de) | 2005-09-14 | 2006-09-08 | Molekulares verfahren zur diagnose von prostatakrebs |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7759060B2 (de) |
| EP (1) | EP1934367B1 (de) |
| AT (1) | ATE486964T1 (de) |
| CA (1) | CA2622440A1 (de) |
| DE (1) | DE602006018038D1 (de) |
| ES (1) | ES2355430T3 (de) |
| WO (1) | WO2007030919A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8008012B2 (en) * | 2002-01-24 | 2011-08-30 | Health Discovery Corporation | Biomarkers downregulated in prostate cancer |
| CA2829776A1 (en) | 2011-03-14 | 2012-09-20 | National Research Council Of Canada | Prognostic marker sets for prostate cancer |
| GB201322034D0 (en) | 2013-12-12 | 2014-01-29 | Almac Diagnostics Ltd | Prostate cancer classification |
| DE102014107380A1 (de) | 2014-05-26 | 2015-11-26 | Eberhard Karls Universität Tübingen Medizinische Fakultät | Verfahren zur Diagnose einer durch den alternativen Weg des Komplementsystems vermittelten Krankheit oder eines Risikos hierfür |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7229774B2 (en) * | 2001-08-02 | 2007-06-12 | Regents Of The University Of Michigan | Expression profile of prostate cancer |
| WO2003016484A2 (en) * | 2001-08-17 | 2003-02-27 | Affymetrix, Inc. | Gleason grade 4/5 prostate cancer genes |
| US6949342B2 (en) | 2001-12-21 | 2005-09-27 | Whitehead Institute For Biomedical Research | Prostate cancer diagnosis and outcome prediction by expression analysis |
| US20040029151A1 (en) * | 2002-04-09 | 2004-02-12 | Affymetrix, Inc. | Molecular genetic profiling of gleason grades 3 and 4/5 prostate cancer |
| ITBZ20020040A1 (it) | 2002-10-11 | 2004-04-12 | Saverio Bettuzzi | Metodo per la identificazione attraverso la progettazione e l'uso di appositi microchip -dna microarray della trasformazione tumorale del tessuto prostatico, valutazione della sua malignita' e prognosi del cancro prostatico umano mediante un nuovo me |
| WO2004091479A2 (en) * | 2003-04-15 | 2004-10-28 | Tularik Inc. | Gene amplification and overexpression in cancer |
| AU2004295712B2 (en) * | 2003-12-01 | 2011-05-19 | Epigenomics Ag | Methods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disorders |
-
2006
- 2006-09-08 EP EP06790654A patent/EP1934367B1/de not_active Not-in-force
- 2006-09-08 AT AT06790654T patent/ATE486964T1/de not_active IP Right Cessation
- 2006-09-08 DE DE602006018038T patent/DE602006018038D1/de active Active
- 2006-09-08 CA CA002622440A patent/CA2622440A1/en not_active Abandoned
- 2006-09-08 ES ES06790654T patent/ES2355430T3/es active Active
- 2006-09-08 WO PCT/CA2006/001477 patent/WO2007030919A1/en active Search and Examination
- 2006-09-13 US US11/519,892 patent/US7759060B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1934367A1 (de) | 2008-06-25 |
| ES2355430T3 (es) | 2011-03-25 |
| ATE486964T1 (de) | 2010-11-15 |
| EP1934367A4 (de) | 2008-10-15 |
| EP1934367B1 (de) | 2010-11-03 |
| US20070065856A1 (en) | 2007-03-22 |
| WO2007030919A1 (en) | 2007-03-22 |
| CA2622440A1 (en) | 2007-03-22 |
| US7759060B2 (en) | 2010-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007072220A3 (en) | Focused microarray and methods of diagnosing cancer | |
| GB2459228A (en) | Exosome-associated microrna as a diagnostic marker | |
| DE602006021038D1 (de) | Verfahren zur diagnose eines ovarialkarzinoms | |
| EP2540840A3 (de) | Genetische Varianten auf CHR16 als Marker zur Verwendung bei der Beurteilung des Risikos, Diagnose, Prognose und Behandlung von Brustkrebs | |
| WO2008146309A3 (en) | Genetic variants on chr 5pl2 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment | |
| EP2186912A3 (de) | Materialien und Verfahren zur Prüfung auf Methylierung von mit Genen assoziierten CpG-Inseln bei der Diagnostizierung von Krebs | |
| ES2530843T3 (es) | Métodos basados en microARN para el diagnóstico de cáncer de páncreas | |
| WO2007028162A3 (en) | Methods and compositions for identifying biomarkers useful in diagnosis and/or treatment of biological states | |
| WO2006012646A3 (en) | Amacr cancer markers | |
| WO2010033371A3 (en) | Molecular markers for lung and colorectal carcinomas | |
| EP2522743A3 (de) | Zum Prostatakrebsrisiko beitragende genetische Varianten | |
| FI2398902T3 (fi) | Menetelmiä ja koostumuksia syövän diagnoosia ja hoitoa varten | |
| WO2005059160A3 (en) | Identification and verification of methylation marker sequences | |
| EP2021794B8 (de) | Verwendung des proteins s100a 12 als marker für kolorektalkarzinom | |
| DE60129151D1 (de) | Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6) | |
| WO2005040421A3 (en) | Prognostic and diagnostic markers for cell proliferative disorders of the breast tissues | |
| WO2006055524A3 (en) | Biomarkers for diagnosing schizophrenia and bipolar disorder | |
| WO2011027310A8 (en) | Novel tumor markers | |
| WO2002022879A3 (en) | Detection of microsatellite instability and its use in diagnosis of tumors | |
| WO2011133770A3 (en) | Salivary protein markers for detection of breast cancer | |
| EP1912066A4 (de) | Hilfsverfahren zur diagnose und therapie von krebs mit nucleolin | |
| WO2008015599A3 (en) | A method of in vivio detection and/or diagnosis of cancer using fluorescence based dna image cytometry | |
| WO2009019370A3 (fr) | Procede de dosage de l'apolipoproteine aii pour le diagnostic in vitro du cancer colorectal | |
| WO2007141595A3 (en) | Method of diagnosing breast cancer using protein markers | |
| DE602006018038D1 (de) | Molekulares verfahren zur diagnose von prostatakrebs |